The EU Drug Strategy (2026–2030), drug policy reforms in candidate countries, and the impact of the war in Ukraine on mental health and substance use were among the key topics
The visit took place at a critical moment, as a new draft law (No. 104, April 2026) proposing more repressive measures toward people who use drugs has passed its first
Eastern and Central European and Central Asian Commission on Drug Policy (ECECACD) co-organised the CND69 side event “EU accession as an opportunity for human rights-based and balanced drug policy reform”
By Aleksander Kwasniewski, Chair of the Eastern and Central European and Central Asian Commission on Drug Policy (ECECACD) and former President of Poland. The Commission’s new EU Drugs Strategy retreats
Eight countries within the Eastern and Central Europe and Central Asia (ECECA) region – Albania, Bosnia and Herzegovina, Montenegro, Northern Macedonia, and Serbia in the Western Balkans, as well as
From 27 to 30 October, the Commission conducted a visit to Montenegro. The timing of the visit was highly favorable, providing strong momentum for advancing drug policy reform, given the
Harm reduction emerged at the height of the HIV epidemic as an innovative approach to curb the spread of HIV among people who inject drugs. At its core, harm reduction
On 23 September, the Informal Group of Members of the European Parliament (MEPs) on Drug Policy was launched at the European Parliament under the leadership of MEP Vytenis Andriukaitis and
June 26, 2025 — In commemoration of the International Day Against Drug Abuse and Illicit Trafficking, Ukraine hosted a high-level visit by Commissioners of the Eastern and Central European and Central Asian
Vytenis Andriukaitis, Member of the European Parliament (MEP) and member of the ECECAD contributed to the round table on April 7, 2025 The round table gathered together decision makers, experts,